Key facts
- It has raised $17.3M; the latest was Early Stage VC ($11.0M) in Feb 2026.
- Notable investors include Alumni Ventures, General Catalyst, SV Angel, Madrona Venture Group, Optum Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Amigo
- ·The full record, as it builds
Funding rounds
No funding rounds for Amigo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Amigo
Developer of an AI-based clinical agent infrastructure designed for healthcare delivery optimization. The company's platform incorporates safety protocols, regulatory compliance mechanisms, and adaptive learning capabilities to support high-stakes medical interactions, enabling healthcare providers to deploy scalable, reliable, and context-aware digital agents that reduce human escalation, improve care quality, and maintain transparency across patient engagements.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 32
- Website
- amigo.ai/
- Ownership
- Privately Held (backing)
Amigo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amigo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amigo in its N-PORT filings yet. We sweep new filings monthly.